Related Experiment Videos
The British system for anticoagulant control and Thrombotest
Journal of Clinical Pathology
|March 1, 1971
Summary
Comparing thromboplastin reagents for anticoagulant therapy revealed that while the British Comparative Thromboplastin and Thrombotest methods are statistically valid, hospital standardization of Thrombotest is unreliable for dosage. Specialist calibration is recommended.
Area of Science:
- Clinical Chemistry
- Hematology
- Medical Diagnostics
Background:
- Accurate monitoring of anticoagulant therapy is crucial for patient safety and treatment efficacy.
- Standardization of laboratory tests is essential for reliable and reproducible results across different healthcare settings.
Purpose of the Study:
- To assess the reliability of comparing the British Comparative Thromboplastin (BCT) and Thrombotest reagents using a national standardization procedure.
- To evaluate the suitability of the recommended standardization method for clinical anticoagulant dosage.
Main Methods:
- A comparative study was conducted using the nationally adopted standardization procedure.
- Statistical validity was assessed for the comparison between BCT and Thrombotest.
Main Results:
- The recommended standardization procedure was found to be statistically valid for comparing BCT and Thrombotest.
- Significant diversion in standardization at individual hospitals using Thrombotest suggests unreliability for clinical anticoagulant dosage.
- Technical errors in standardization procedures are likely the cause of observed diversions.
Conclusions:
- While the comparison method is valid, hospital-level standardization of Thrombotest is not sufficiently reliable for determining anticoagulant dosage.
- Thrombotest should be calibrated against the British Comparative Thromboplastin exclusively in specialist coagulation centers proficient in both techniques.